Re Agreement

Futura Medical PLC
19 January 2004




Press Release                                     19 January 2004



       Futura Medical plc enters into agreement with CST Medical Limited

On 13th January 2004 Futura Medical plc ('Futura' or 'the Company'), the
AIM-listed pharmaceutical and medical device group that develops innovative
products for the sexual healthcare market, entered into an agreement with CST
Medical Limited ('CST'), a private company that specialises in developing
products to address female sexual dysfunction.  The agreement is in settlement
of an intellectual property dispute.  The agreement enables Futura to
participate in the future success of CST.

Under the agreement CST will transfer certain intellectual property to Futura.
Futura will also receive 10 per cent of the issued share capital of CST as at
the date of the agreement, prior to any subsequent dilution due to fundraising
by CST, and a royalty in respect of sales of the Vielle stimulator up to 31
December 2008.

James Barder, Chief Executive of Futura Medical plc, said: 'Futura specialises
in developing products for sexual health and wellbeing and we believe that as a
product for the treatment of female sexual dysfunction, the Vielle stimulator
addresses a previously unmet need affecting an estimated two in five of the
female population at some time in their lives.'





For further information:
Futura Medical plc
James Barder, Chief Executive                   Tel: [phone]
mailto:[e-mail]         www.futuramedical.co.uk



Media enquiries:
Bankside
Peter Curtain / Alex Tweed                      Tel: [phone]
mailto:[e-mail]             www.bankside.com




                      This information is provided by RNS
            The company news service from the London Stock Exchange